Methyl 4-Hydroxy-1-Methyl-7-Phenoxy-3-Isoquinolinecarboxylate: A Vital Pharmaceutical Intermediate
Explore the critical role of this compound in synthesizing advanced therapeutics and its applications in research.
Get a Quote & SampleProduct Core Value
Methyl 4-Hydroxy-1-Methyl-7-Phenoxy-3-Isoquinolinecarboxylate
This high-purity chemical serves as a crucial building block in the pharmaceutical industry, particularly as an intermediate for Roxadustat. Its precise chemical structure and quality are essential for developing effective treatments for conditions such as anemia and chronic renal insufficiency. The synthesis of this compound is a key step in the overall drug manufacturing process.
- Discover efficient methyl 4-hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylate synthesis pathways for bulk drug intermediates.
- Understand the importance of this CAS 1421312-34-6 compound in roxadustat intermediate manufacturing processes.
- Learn about the applications of this molecule in anemia treatment drug development, ensuring efficacy and safety.
- Source high purity isoquinolinecarboxylate derivatives for your advanced chemical synthesis needs.
Key Advantages
Exceptional Purity
Ensuring the highest purity levels for critical pharmaceutical intermediate synthesis, vital for scientific research chemical suppliers.
Roxadustat Synthesis Intermediate
A cornerstone intermediate in the production of Roxadustat, aiding in the fight against anemia and related conditions.
Versatile Chemical Building Block
Offers a robust foundation for various fine chemical manufacturing processes and the creation of novel compounds.
Key Applications
Pharmaceutical Synthesis
A primary component in the complex synthesis of active pharmaceutical ingredients, supporting advancements in medicine.
Drug Development
Crucial for the research and development of new drugs, particularly those targeting hematological disorders.
Scientific Research
A valuable reagent for academic and industrial labs exploring novel chemical reactions and material properties.
Anemia Treatment
Directly contributes to the manufacturing of treatments for anemia, improving patient health outcomes.